Literature DB >> 23895999

Multilayer nanoparticles for sustained delivery of exenatide to treat type 2 diabetes mellitus.

Jae Yeon Kim1, Hwanbum Lee, Keun Sang Oh, Seho Kweon, Ok-cheol Jeon, Youngro Byun, Kwangmeyung Kim, Ick Chan Kwon, Sang Yoon Kim, Soon Hong Yuk.   

Abstract

A method for the sustained delivery of exenatide was proposed using nanoparticles (NPs) with a core/shell structure. The interactions between lipid bilayers and Pluronics were utilized to form various NPs using a layer-by-layer approach. Transmittance electron microscopy and dynamic light scattering were used to examine the morphology of the NPs. The in vitro release pattern was observed as a function of changes in the structure of the NPs, and the structural integrity of exenatide released was examined by SDS-PAGE analysis. Pharmacokinetics and antidiabetic effects were also observed with the structural change of NPs using in vivo animal models. In vitro-in vivo correlation was discussed in relation to manipulation of the NP structures.
© 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Core/shell nanoparticles; Layer-by-layer approach; Lipid bilayers; Pluronics; Sustained delivery of exenatide

Mesh:

Substances:

Year:  2013        PMID: 23895999     DOI: 10.1016/j.biomaterials.2013.07.040

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  7 in total

1.  An intestinal paracellular pathway biased toward positively-charged macromolecules.

Authors:  Khaled Almansour; Alistair Taverner; Jerrold R Turner; Ian M Eggleston; Randall J Mrsny
Journal:  J Control Release       Date:  2018-09-06       Impact factor: 9.776

2.  Microcosmic mechanism of dication for inhibiting acylation of acidic Peptide.

Authors:  Feng Qi; Liuqing Yang; Jie Wu; Guanghui Ma; Zhiguo Su
Journal:  Pharm Res       Date:  2015-01-14       Impact factor: 4.200

3.  Progesterone PLGA/mPEG-PLGA Hybrid Nanoparticle Sustained-Release System by Intramuscular Injection.

Authors:  Bin Xie; Yang Liu; Yuting Guo; Enbo Zhang; Chenguang Pu; Haibing He; Tian Yin; Xing Tang
Journal:  Pharm Res       Date:  2018-02-14       Impact factor: 4.200

4.  Long-Acting Phospholipid Gel of Exenatide for Long-Term Therapy of Type II Diabetes.

Authors:  Mei Hu; Yu Zhang; Nanxi Xiang; Ying Zhong; Tao Gong; Zhi-Rong Zhang; Yao Fu
Journal:  Pharm Res       Date:  2016-02-08       Impact factor: 4.200

Review 5.  Improving long-term subcutaneous drug delivery by regulating material-bioenvironment interaction.

Authors:  Wei Chen; Bryant C Yung; Zhiyong Qian; Xiaoyuan Chen
Journal:  Adv Drug Deliv Rev       Date:  2018-01-31       Impact factor: 15.470

6.  Microneedle-array patches loaded with dual mineralized protein/peptide particles for type 2 diabetes therapy.

Authors:  Wei Chen; Rui Tian; Can Xu; Bryant C Yung; Guohao Wang; Yijing Liu; Qianqian Ni; Fuwu Zhang; Zijian Zhou; Jingjing Wang; Gang Niu; Ying Ma; Liwu Fu; Xiaoyuan Chen
Journal:  Nat Commun       Date:  2017-11-24       Impact factor: 14.919

7.  Multiseed liposomal drug delivery system using micelle gradient as driving force to improve amphiphilic drug retention and its anti-tumor efficacy.

Authors:  Wenli Zhang; Caibin Li; Ya Jin; Xinyue Liu; Zhiyu Wang; John P Shaw; Bruce C Baguley; Zimei Wu; Jianping Liu
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.